CuTPCTR1HlyIIIidc:CuTPidc:CTR1idc:HlyIIIidc:RhopH3idc:RhopH2RhopH3RhopH2 idc:CLAG3.1 CLAG3.1 CLAG3.2 idc:CLAG3.2

Online articles related to Possible reasons for increased permeability of host cell membrane retrieved from PubMed

RX Drugs affecting pathway with unknown specific target

Drug Name PubMed Articles (year of publication)
(E)-3-((13S)-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-2-yl)-1-phenylprop-2-en-1-one
2-(3,3-diphenylpropylamino)-5-nitro-benzoic acid
2-(4-methoxyphenyl)-5H-thiazolo[4,5-c]quinolin-4-one
2-[2-(4-methoxyphenyl)ethylamino]-5-nitro-benzoic acid
2-amino-1-((2-amino-3-oxobutyl)disulfaneyl)-5-((7-chloroquinolin-4-yl)amino)pentan-3-one
2-butyl-5-imino-6-{[5-(4-nitrophenyl)-2-furyl]methylene}-5,6-dihydro-7h-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
3-(4-phenylpiperazine-1-carbonyl)-5H-benzo[b][1,4]benzothiazepin-6-one
3-[(1-naphthylmethylamino)methyl]-4-phenyl-5-sulfinamoyl-benzoic acid
3-[3-(2-naphthyl)propyl]-4-phenyl-5-sulfinamoyl-benzoic acid
3-[5-[4-(2,5-dimethylphenyl)piperazin-1-yl]sulfonyl-2-thienyl]-1H-pyridazin-6-one
3-{3-[4-(7-Chloro-quinolin-4-yl)-piperazin-1-ylmethyl]-4-hydroxy-5- methoxyphenyl}-1-(2,4-dimethoxy-phenyl)-propenone
4-(4-((4-(3-methylpyrazin-2-yl)piperazin-1-yl)sulfonyl)cyclopenta-1,3-dien-1-yl)cyclohexa-2,4-dien-1-one
4-(4-((4-(o-tolyl)piperazin-1-yl)sulfonyl)cyclopenta-1,3-dien-1-yl)cyclohexa-2,4-dien-1-one
4,4 -diisothiocyanostilbene- 2,2 -disulfonic acid
4-chloro-5-nitro-2-(3-phenylpropylamino)benzoic acid
4-methyl-3-[(1-naphthylmethylamino)-(2-thienyl)methyl]-5-sulfinamoyl-benzoic acid
5-nitro-2-(3-phenylpropylamino)benzoate
5-nitro-2-(3-phenylpropylamino)benzoic acid
5-nitro-2-(4-phenylbutylamino)benzoic acid
7-methyl-N-(m-tolyl)-N-propyl-furo[2,3-b]quinoline-2-carboxamide
8-oh-dpat
Alkoxylated chalcones
Artemisinin
Arvanil
Asp-Arg-Asp-Val-Lys-Tyr-Ile-His-Pro-Phe
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe
Benzylthiazolium
Blasticidin s
Bradikynin
Dantrolene
D-Asp-D-Arg-D-Asp-D-Val-D-Lys-D-Tyr-D-Ile-D-His-D-Pro-D-Phe
D-Asp-D-Arg-D-Val-D-Tyr-D-Ile-D-His-D-Pro-D-Phe
Furoquinoline
Furosemide
Glybenclamide
Hydroxylated chalcones
Ispa-28
Lauryl-lysine
Leupeptin
Mmv007384
N-(1-benzylpropyl)-6-oxo-5H-benzo[b][1,4]benzothiazepine-3-carboxamide
N-benzyl-N-ethyl-6-oxo-5H-benzo[b][1,4]benzothiazepine-3-carboxamide
N-butyl-N-ethyl-7-methyl-furo[2,3-b]quinoline-2-carboxamide
Niflumate
Nk-2, a peptide representing the cationic core region of the lymphocytic effector protein nk-lysin
Nppb
Phe-Pro-His-Ile-Tyr-Val-Arg-Asp
Phloretin-2-beta-glucoside
Phosphinic acid
P-nitrophenyl phosphate
RPGLPVRFESPL-NH2
STAD-2
Succinimidyl-6-(biotinamido)hexanoate
Sulfo-nhs-lc-biotin

Possible reasons for increased permeability of host cell membrane map details

PFID PFID Old Annotation Formal Annotation EC Transcript
PF3D7_0302500 loop drugs PFC0120w CLAG3.1 cytoadherence linked asexual protein 3.1 pie diagram
PF3D7_0302200 loop drugs PFC0110w CLAG3.2 cytoadherence linked asexual protein 3.2 pie diagram
PF3D7_1439000 loop PF14_0369 CTR1 copper transporter, CTR1 pie diagram
PF3D7_0904900 loop drugs PFI0240c CuTP copper-transporting ATPase 3.6.3.4 pie diagram
PF3D7_1455400 loop PF14_0528 HlyIII hemolysin III pie diagram
PF3D7_0929400 loop PFI1445w RhopH2 high molecular weight rhoptry protein 2 pie diagram
PF3D7_0905400 loop PFI0265c RhopH3 high molecular weight rhoptry protein 3 pie diagram